FDA Approves TRETINOIN — Amneal Pharmaceuticals NY LLC

# FDA Approves Amneal Pharmaceuticals' Generic Tretinoin Topical Formulation Amneal Pharmaceuticals NY LLC received FDA approval for its generic tretinoin topical formulation (ANDA217497), expanding the competitive landscape in the dermatological retinoid market and potentially increasing price competition for this widely-prescribed acne and anti-aging treatment. The approval is expected to provide patients with more affordable treatment options while allowing Amneal to capture additional market share in the generic skincare pharmaceutical segment.